Buys
Open market- Shares
- +321,672
- Avg price
- $2.42
- Total value
- +$779,626
RA CAPITAL MANAGEMENT, L.P. - Director, 10%+ Owner at Climb Bio, Inc.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- CLYM on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for RA CAPITAL MANAGEMENT, L.P. in Climb Bio, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +321,672
- Share %
- 100%
- Total value
- +$779,626
Reported holdings for RA CAPITAL MANAGEMENT, L.P. in Climb Bio, Inc.
Form 4 holding
Director, 10%+ Owner
Climb Bio, Inc.
- Security class
- Common Stock
- Shares / value
- 3,403,429
- Estimated value
- $11,912,001
- Report date
- 05 Jan 2026
- Price
- $3.50
- Ownership
- Indirect
Form 4 holding
Director
Climb Bio, Inc.
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 22,546,000
- Estimated value
- Report date
- 29 Apr 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Climb Bio, Inc.
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 22,546,000
- Estimated value
- Report date
- 29 Apr 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Climb Bio, Inc.
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 22,546,000
- Estimated value
- Report date
- 29 Apr 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Climb Bio, Inc.
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 22,546,000
- Estimated value
- Report date
- 29 Apr 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Climb Bio, Inc.
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 22,546,000
- Estimated value
- Report date
- 29 Apr 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Climb Bio, Inc.
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 22,546,000
- Estimated value
- Report date
- 29 Apr 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Climb Bio, Inc.
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 22,546,000
- Estimated value
- Report date
- 29 Apr 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Climb Bio, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 70,284
- Estimated value
- Report date
- 29 Jun 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Climb Bio, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 70,284
- Estimated value
- Report date
- 29 Jun 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Climb Bio, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 70,284
- Estimated value
- Report date
- 29 Jun 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Climb Bio, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 70,284
- Estimated value
- Report date
- 29 Jun 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Climb Bio, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 70,284
- Estimated value
- Report date
- 29 Jun 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Climb Bio, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 70,284
- Estimated value
- Report date
- 29 Jun 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Climb Bio, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 70,284
- Estimated value
- Report date
- 29 Jun 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for RA CAPITAL MANAGEMENT, L.P. in Climb Bio, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.